GB Meka
Stocks to watch

SRPT

Compare

SAREPTA THERAPEUTICS INC · Healthcare

$18.46
▼ 1.0%Close 2026-09-30

Live intraday price

Compare with our price levels

T220.88
T120.17
E116.90
E313.75
SL12.62

Close 2026-09-30: $18.46 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting▼ Leaning negative

Not in the buy zone yet — needs to drop 8.5% · 1 whale recently bought

1 month
▼ 12.2%
3 months
▲ 1.4%
1 year
▼ 1.9%
Analyst target
$21.86 +18.4%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$16.90 -8.5%
E2$15.43 -16.4%
E3$13.75 -25.5%
Targets
T1$20.17 9.3%
T2$20.88 13.1%
T3$23.79 28.9%
Stop-loss
SL$12.62 -31.6%
Whale cost ~$18.34 -0.7%

Risk : reward 1 : 2.0Moves ~$1.13 a day

⚖️ Positives and risks

✓ Positives (2)
  • ●เซียนซื้อใหม่/ซื้อเพิ่มไตรมาสล่าสุด 1 ราย
  • ●ราคาเป้าหมายนักวิเคราะห์เฉลี่ย 21.86 (upside +18%, 22 ราย)
! Risks (4)
  • ●เซียนขายออก/ลดสัดส่วน 1 ราย: Joel Greenblatt (ขายหมด)
  • ●อ่อนแอกว่าตลาด (S&P 500) -34% ใน 6 เดือน
  • ●รายได้หดตัว -34% เทียบปีก่อน
  • ●บริษัทยังขาดทุน (อัตรากำไรสุทธิติดลบ)

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

Mayo Stephen · Director

2026-03-12 · 7,239 shares @ $17.02

$123,208
Sell

Estepan Ian Michael · COO

2025-12-16 · 13,187 shares @ $22.31

$294,202

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

No news yet (we only fetch news for stocks with a signal or a high whale score)

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$2.0B
Next earnings2026-11-04
P/E (price to earnings)-
Forward P/E (on expected earnings)7.1
Revenue growth (YoY)-34.3%
Earnings growth (YoY)-
Net profit margin-6.9%
ROE-9.5%
Debt to equity (D/E)70%
Dividend yield-
Analyst targets (high / low)$38.00 / $5.00
Number of analysts22
Trend and technical indicators
Trend short / mid / longDowntrend ↘ · Sideways → · Sideways →
RSI43
MA50 / MA200$18.79 / $19.16
Distance from MA200-3.6%
MACDNegative
1-year high / low$25.32 / $14.68
vs. S&P 500 (6 months)-33.9%
Volume vs. average0.17×